Emerging Mass Spec Innovator Target customers in proteomics and biomarker discovery should be prioritized, as MOBILion’s high-resolution SLIM technology and rapid workflows address gaps in sensitivity and speed across mass spectrometry workflows.

ASMS Engagement Leverage active conference participation and planned ASMS showcases to schedule demonstrations with attendees, focusing on MOBIE platform expansions and PAMAF as a next-generation workflow.

Proteomics Platform Expansion Position opportunities around advancing proteomics capabilities by integrating MOBILion’s high-resolution ion mobility with existing MS setups, appealing to labs upgrading from traditional MS for faster, deeper analyses.

Strategic Partnerships Explore collaborations with biotech firms and contract research organizations seeking safer, more effective biologics characterization and diagnostic assay development through enhanced separation and analysis.

Growth Readiness With mid-market revenue and substantial funding, pursue mid-to-large scale lab deployments and pilot projects that demonstrate ROI in complex molecular separations, enabling scale-up of proteomics and diagnostic workflows.